Evidence map›Paper›PMID 34660350›Full record

ArticleFrontiers in cellular and infection microbiology2021

Na Yao, Jia-Kang He, Ming Pan, Zhao-Feng Hou, Jin-Jun Xu, Yi Yang, Jian-Ping Tao, Si-Yang Huang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Use ofHeliyon · 2023
    Article
  11. The anti-Frontiers in veterinary science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Na YaoInstitute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Jia-Kang HeCollege of Animal Science and Technology, Guangxi University, Nanning, China.
Ming PanInstitute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Zhao-Feng HouInstitute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Jin-Jun XuInstitute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Yi YangCollege of Animal Sciences, Zhejiang Provincial Key Laboratory of Preventive Veterinary Medicine, Institute of Preventive Veterinary Medicine, Zhejiang University, Hangzhou, China.
Jian-Ping TaoInstitute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Si-Yang HuangInstitute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Yangzhou University · CNGuangxi University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current methods of treating toxoplasmosis have a number of side effects, and these therapies are only effective against the acute stage of the disease. Thus, development of new low toxicity and efficient anti-

Indexed as

LavandulaOils, VolatileToxoplasmaToxoplasmosisFibroblastsHumansOils, Volatilein vitroLavandula angustifolia essential oilnatural medicineToxoplasma gondiitreatment

Identifiers

PMID34660350
PMCPMC8513107
OpenAlexW3204369233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.